Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml recalled

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml. Mölnlycke Health Care is recalling specific batches of Hibiwash due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring.

Pharmacists are advised to stop using and supplying the specific batches of Hibiwash immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. Healthcare professionals responsible for the management of patients with cystic fibrosis or awaiting lung transplant who have been supplied with Hibiwash since 10 February 2026 should contact patients directly. 

Further information, actions and details of the affected batches can be found on the MHRA website.